A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Ranging Study Assessing Efficacy and Safety of SB208 and Vehicle Gel in Subjects With Interdigital Tinea Pedis

Trial Profile

A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Ranging Study Assessing Efficacy and Safety of SB208 and Vehicle Gel in Subjects With Interdigital Tinea Pedis

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Onychomycosis; Tinea pedis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Novan Inc
  • Most Recent Events

    • 11 Jan 2018 Results presented in a Novan Media Release.
    • 11 Jan 2018 According to a Novan media release, data will be presented at the Winter Clinical Dermatology Conference.
    • 14 Dec 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top